TABLE 1.
68Ga-DOTA-2P(FAPI)2 Dosimetry Summary of Effective Doses Using OLINDA/EXM, Version 1.1
| Target organ | Mean (mSv/MBq) | SD (mSv/MBq) |
|---|---|---|
| Adrenal glands | 7.98E−05 | 3.04E−05 |
| Brain | 3.16E−05 | 1.96E−05 |
| Breasts | 6.36E−05 | 1.09E−05 |
| Gallbladder wall | — | — |
| Lower large intestine wall | 9.22E−04 | 2.33E−04 |
| Small intestine | 5.18E−05 | 1.84E−05 |
| Stomach wall | 7.12E−04 | 3.16E−05 |
| Upper large intestine wall | 2.79E−05 | 1.13E−05 |
| Heart wall | — | — |
| Kidneys | 1.01E−04 | 4.96E−05 |
| Liver | 1.65E−03 | 4.12E−04 |
| Lungs | 1.36E−03 | 4.59E−04 |
| Muscle | 4.19E−05 | 2.07E−05 |
| Ovaries | 5.94E−04 | 1.06E−04 |
| Pancreas | 7.61E−04 | 8.05E−04 |
| Red marrow | 1.12E−03 | 1.33E−04 |
| Osteogenic cells | 6.47E−05 | 6.87E−06 |
| Skin | 1.22E−05 | 2.32E−06 |
| Spleen | 1.58E−04 | 9.12E−05 |
| Thymus | 9.64E−06 | 4.47E−06 |
| Thyroid | 3.11E−03 | 4.68E−04 |
| Urinary bladder wall | 1.04E−03 | 5.22E−04 |
| Uterus | 1.27E−05 | 6.00E−06 |
| Effective dose equivalent | 1.69E−02 | 1.92E−03 |
| Effective dose | 1.19E−02 | 9.45E−04 |